Human mesenchymal stem cells in rodent whole embryo culture are reprogrammed to contribute kidney tissues
Yokoo T, Ohashi T, Shen J-S, et al. Human mesenchymal stem cells in rodent whole embryo culture are reprogrammed to contribute kidney tissues. Proc Natl Acad Sci USA. 2005;102: 3296-300.
Xenobiotic kidney organogenesis from human mesenchymal stem cells using a growing rodent embryo
Yokoo T, Fukui A, Ohashi T, et al. Xenobiotic kidney organogenesis from human mesenchymal stem cells using a growing rodent embryo. J Am Soc Nephrol. 2006;17: 1026-34.
Generation of transplantable erythropoietin producer derived from human mesenchymal stem cells
Yokoo T, Fukui A, Matsumoto K, et al. Generation of transplantable erythropoietin producer derived from human mesenchymal stem cells. Transplantation. 2008;85: 1654-8.
Bone marrow progenitors from animals with chronic renal failure lack capacity of in vitro proliferation
Drewa T, Joachimiak R, Kaznica A, Flisinski M, Brymora A, Manitius J. Bone marrow progenitors from animals with chronic renal failure lack capacity of in vitro proliferation. Transplant Proc. 2008;40: 1668-73.
Mesenchymal stem cells derived from adipose tissue are not affected by renal disease
doi: 10. 1038/ki. 2012. 187
Roemeling-van Rhijn M, Reinders ME, de Klein A, et al. Mesenchymal stem cells derived from adipose tissue are not affected by renal disease. Kidney Int. 2012. doi: 10. 1038/ki. 2012. 187.
Bone marrow-derived mesenchymal stem cells ameliorate hepatic ischemia reperfusion injury in a rat model
doi:10.1371/journal.pone.0019195
Kanazawa H, Fujimoto Y, Teratani T, et al. Bone marrow-derived mesenchymal stem cells ameliorate hepatic ischemia reperfusion injury in a rat model. PLoS ONE. 2011;. doi: 10. 1371/journal. pone. 0019195.
Proteasome inhibitors improve the function of mutant lysosomal alpha-glucosidase in fibroblasts from Pompe disease patient carrying c.546G>T mutation
Shimada Y, Nishida H, Nishiyama Y, et al. Proteasome inhibitors improve the function of mutant lysosomal alpha-glucosidase in fibroblasts from Pompe disease patient carrying c. 546G>T mutation. Biochem Biophys Res Commun. 2011;415: 274-8.